AIM ImmunoTech Inc (AIM)
NYSE MKT:AIM

AIM ImmunoTech (AIM) Stock Investors

775 Followers
Based on 649,844 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold AIM
On average, investors allocate 2.68% of their portfolios to AIM
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding AIM

6.0%
Last 7
Days
5.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding AIM, out of 649,844 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

AIM Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.23%
$0.49
Based on the activity of 12,166 investors who made their portfolios public
The table shows changes in AIM in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

AIM Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.65%
-0.59%
-0.21%
$49.13B
Healthcare
General Electric
5.82%
+0.06%
+2.07%
$111.51B
Industrials
Nikola
5.39%
-1.12%
-2.61%
$423.40M
Energy
Syros Pharmaceuticals
3.88%
-1.41%
-5.31%
$77.23M
Healthcare
DraftKings
6.00%
-0.65%
-0.01%
$19.91B
Technology
Plug Power
4.54%
-0.25%
+1.44%
$5.31B
Energy
Barrick Gold
6.27%
-0.61%
+0.28%
$29.50B
Basic Materials
AMC Entertainment
6.46%
-0.94%
-2.48%
$7.01B
Consumer Cyclical
Li Auto
5.42%
-0.27%
+3.63%
$27.86B
Consumer Cyclical
Trade Desk
4.95%
-0.48%
+0.80%
$34.21B
Technology
Based on the activity of 649,844 active portfolios
Open your Smart Portfolio

AIM Investor Analysis

AIM investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.1%
of AIM holders
are under 35
Average Segment Performance
Average P/E Ratio35.81
Beta4.94
Dividend Yield4.82%
AIM investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
45.2%
of AIM holders
are between 35–55
Average Segment Performance
Average P/E Ratio39.23
Beta4.86
Dividend Yield5.08%
AIM investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
39.7%
of AIM holders
are over 55
Average Segment Performance
Average P/E Ratio39.79
Beta0.43
Dividend Yield5.11%
Overview of age group and performance of AIM stock investors
See who invests in AIM according to age group and performance.

FAQ

How many retail Investors hold AIM?
<0.1% of TipRank’s retail investors hold AIM in their portfolios.
    What is AIM Investor Sentiment?
    AIM’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of AIM in the last 7 days?
      ▼ 6.0% of TipRank’s retail investors changed their holding of AIM in the last 7 days.
        What percentage of retail investors changed their holding of AIM in the last 30 days?
        ▼ 5.8% of TipRank’s retail investors changed their holding of AIM in the last 30 days.
          What is the average age of retail investors who hold AIM?
          The average age of AIM Holders is between 35–55.
            What other stocks have AIM investors also bought?
            AIM Investors also bought MRNA, GE, NKLA, SYRS, DKNG, PLUG, GOLD, AMC, LI, TTD.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABCAmerisourceBergen
              BCRXBioCryst
              BLRXBioline RX Ltd Sponsored ADR
              BIOBio-Rad Laboratories
              CTICCTI BioPharma

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis